Natera, Inc. (NTRA)
NASDAQ: NTRA · Real-Time Price · USD
410.35
+1.88 (0.46%)
At close: Oct 2, 2026, 4:00 PM EDT
410.29
-0.06 (-0.01%)
Pre-market: Oct 5, 2026, 6:11 AM EDT
Natera Employees
Natera had 6,140 employees as of December 31, 2025. The number of employees increased by 1,706 or 38.48% compared to the previous year.
Employees
6,140
Change (1Y)
1,706
Growth (1Y)
38.48%
Revenue / Employee
$440,892
Profits / Employee
-$31,327
Market Cap
59.15B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 6,140 | 1,706 | 38.48% |
| Dec 31, 2024 | 4,434 | 1,141 | 34.65% |
| Dec 31, 2023 | 3,293 | 275 | 9.11% |
| Dec 31, 2022 | 3,018 | 348 | 13.03% |
| Dec 31, 2021 | 2,670 | 855 | 47.11% |
| Dec 31, 2020 | 1,815 | 776 | 74.69% |
| Dec 31, 2019 | 1,039 | 64 | 6.56% |
| Dec 31, 2018 | 975 | 82 | 9.18% |
| Dec 31, 2017 | 893 | 41 | 4.81% |
| Dec 31, 2016 | 852 | 136 | 18.99% |
| Dec 31, 2015 | 716 | 42 | 6.23% |
| Dec 31, 2014 | 674 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| IQVIA Holdings | 93,000 |
| Labcorp Holdings | 71,000 |
| Danaher | 60,000 |
| Quest Diagnostics | 57,000 |
| Agilent Technologies | 18,100 |
| Mettler-Toledo International | 18,100 |
| IDEXX Laboratories | 11,000 |
| Revvity | 11,000 |
NTRA News
- 3 days ago - Natera price target raised to $475 from $360 at Guggenheim - TheFly
- 4 days ago - The Top HealthTech Questions Landing on Our Desks - ETF Trends
- 9 days ago - Natera price target raised to $460 from $350 at RBC Capital - TheFly
- 12 days ago - Natera announces Signatera receives regulatory approval in Japan - TheFly
- 12 days ago - Signatera™ Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer - Business Wire
- 17 days ago - Largest MRD Study in Lung Cancer Highlights Strong Prognostic Value for SignateraTM - Business Wire
- 19 days ago - Natera Transcript: 2026 Global Healthcare Conference - Transcripts
- 20 days ago - Natera Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts